| Lindsay Lawrence, DO | |
|
3336 S Pioneer Pkwy Ste 301, West Valley City, UT 84120-2073 | |
| (801) 964-3865 | |
| Not Available |
| Full Name | Lindsay Lawrence |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 3336 S Pioneer Pkwy Ste 301, West Valley City, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548622756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 11779201-1204 (Utah) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jordan Valley Medical Center | West jordan, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity. The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.
Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
METTLER TOLEDO is proud to offer a complete portfolio of high-quality balances along with the know-how to help you choose the right one for your lab application and budget.
› Verified 6 days ago
| Entity Name | Physician Group Of Utah Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477676930 PECOS PAC ID: 8022032234 Enrollment ID: O20060113000886 |
News Archive
VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity. The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.
Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
METTLER TOLEDO is proud to offer a complete portfolio of high-quality balances along with the know-how to help you choose the right one for your lab application and budget.
› Verified 6 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942903562 PECOS PAC ID: 8022927342 Enrollment ID: O20230615001995 |
News Archive
VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity. The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.
Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
METTLER TOLEDO is proud to offer a complete portfolio of high-quality balances along with the know-how to help you choose the right one for your lab application and budget.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Lawrence, DO 1336 Scrub Oak Cir, Boulder, CO 80305-6256 Ph: () - | Lindsay Lawrence, DO 3336 S Pioneer Pkwy Ste 301, West Valley City, UT 84120-2073 Ph: (801) 964-3865 |
News Archive
VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity. The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.
Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
METTLER TOLEDO is proud to offer a complete portfolio of high-quality balances along with the know-how to help you choose the right one for your lab application and budget.
› Verified 6 days ago
Alton D Burgett, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3725 W 4100 S, West Valley City, UT 84120 Phone: 801-965-3600 Fax: 801-965-3526 | |
David B Isaac, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3725 W 4100 S, West Valley City, UT 84120 Phone: 801-965-3600 Fax: 801-965-3526 | |
Maria Alejandra Gonzalez Ferrua, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3336 S Pioneer Pkwy Ste 301, West Valley City, UT 84120 Phone: 801-964-3865 | |
Stephen D Lash, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3336 S 4155 W, Ste 301, West Valley City, UT 84120 Phone: 801-964-3865 | |
Steven C Dinger, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3725 W 4100 S, West Valley City, UT 84120 Phone: 801-965-3600 Fax: 801-965-3526 |